Literature DB >> 19170109

Msx2 induces epithelial-mesenchymal transition in mouse mammary epithelial cells through upregulation of Cripto-1.

M G di Bari1, E Ginsburg, J Plant, L Strizzi, D S Salomon, B K Vonderhaar.   

Abstract

Epithelial-mesenchymal transition (EMT) is a process occurring during both embryogenesis and early stages of invasive cancer. Epithelial cells that undergo EMT become more migratory and invasive with a mesenchymal morphology. Herein we assess EMT induction in a mouse mammary epithelial cell line driven by Msx2, a homeobox-containing transcription factor important during mammary gland development. NMuMG cells, a normal mouse mammary epithelial cell line, stably transfected with a Msx2 cDNA showed downregulation of an epithelial marker E-cadherin and upregulation of the mesenchymal markers vimentin and N-cadherin. Furthermore, overexpression of Cripto-1, a member of the epidermal growth factor-CFC protein family already known to be involved in EMT, was detected in Msx2-transfected cells. The expression of Cripto-1 was accompanied by activation of the tyrosine kinase c-Src pathway and an increase in the invasive ability of the cells. Functional assays also demonstrated inhibition of the invasive behavior of the Msx2-transfected cells by a c-Src specific inhibitor. Moreover, immunohistochemistry of human infiltrating breast carcinomas showed positive staining for Msx2 only in the infiltrating tumor cells while the non-infiltrating tumor cells were negative. These results suggest that Msx2 may play a significant role in promoting EMT in epithelial cells that acquire properties involved in tumor invasion. J. Cell. Physiol. 219: 659-666, 2009. Published 2009 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19170109      PMCID: PMC2753837          DOI: 10.1002/jcp.21712

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  30 in total

Review 1.  Epithelial-mesenchymal transitions in tumour progression.

Authors:  Jean Paul Thiery
Journal:  Nat Rev Cancer       Date:  2002-06       Impact factor: 60.716

Review 2.  Deregulated homeobox gene expression in cancer: cause or consequence?

Authors:  Cory Abate-Shen
Journal:  Nat Rev Cancer       Date:  2002-10       Impact factor: 60.716

3.  A Nodal- and ALK4-independent signaling pathway activated by Cripto-1 through Glypican-1 and c-Src.

Authors:  Caterina Bianco; Luigi Strizzi; Aasia Rehman; Nicola Normanno; Christian Wechselberger; Youping Sun; Nadia Khan; Morihisa Hirota; Heather Adkins; Kevin Williams; Richard U Margolis; Michele Sanicola; David S Salomon
Journal:  Cancer Res       Date:  2003-03-15       Impact factor: 12.701

4.  Cripto-1 activates nodal- and ALK4-dependent and -independent signaling pathways in mammary epithelial Cells.

Authors:  Caterina Bianco; Heather B Adkins; Christian Wechselberger; Masaharu Seno; Nicola Normanno; Antonella De Luca; Youping Sun; Nadia Khan; Nicholas Kenney; Andreas Ebert; Kevin P Williams; Michele Sanicola; David S Salomon
Journal:  Mol Cell Biol       Date:  2002-04       Impact factor: 4.272

5.  Cripto-1 enhances migration and branching morphogenesis of mouse mammary epithelial cells.

Authors:  C Wechselberger; A D Ebert; C Bianco; N I Khan; Y Sun; B Wallace-Jones; R Montesano; D S Salomon
Journal:  Exp Cell Res       Date:  2001-05-15       Impact factor: 3.905

6.  The prognostic significance of epithelial-mesenchymal transition in breast cancer.

Authors:  Ilka B Fuchs; Werner Lichtenegger; Helmut Buehler; Wolfgang Henrich; Harald Stein; Anke Kleine-Tebbe; Gerhard Schaller
Journal:  Anticancer Res       Date:  2002 Nov-Dec       Impact factor: 2.480

Review 7.  Epithelial-mesenchymal transition and its implications for fibrosis.

Authors:  Raghu Kalluri; Eric G Neilson
Journal:  J Clin Invest       Date:  2003-12       Impact factor: 14.808

8.  The gatekeeper effect of epithelial-mesenchymal transition regulates the frequency of breast cancer metastasis.

Authors:  Chengsen Xue; David Plieth; Christo Venkov; Carol Xu; Eric G Neilson
Journal:  Cancer Res       Date:  2003-06-15       Impact factor: 12.701

Review 9.  Regulation of mammary gland branching morphogenesis by the extracellular matrix and its remodeling enzymes.

Authors:  Jimmie E Fata; Zena Werb; Mina J Bissell
Journal:  Breast Cancer Res       Date:  2003-08-19       Impact factor: 6.466

10.  Msx1 and Msx2 are required for endothelial-mesenchymal transformation of the atrioventricular cushions and patterning of the atrioventricular myocardium.

Authors:  Yi-Hui Chen; Mamoru Ishii; Henry M Sucov; Robert E Maxson
Journal:  BMC Dev Biol       Date:  2008-07-30       Impact factor: 1.978

View more
  22 in total

Review 1.  The multifaceted role of the embryonic gene Cripto-1 in cancer, stem cells and epithelial-mesenchymal transition.

Authors:  Malgorzata Klauzinska; Nadia P Castro; Maria Cristina Rangel; Benjamin T Spike; Peter C Gray; Daniel Bertolette; Frank Cuttitta; David Salomon
Journal:  Semin Cancer Biol       Date:  2014-08-19       Impact factor: 15.707

2.  MSX2 is an oncogenic downstream target of activated WNT signaling in ovarian endometrioid adenocarcinoma.

Authors:  Y Zhai; A Iura; S Yeasmin; A B Wiese; R Wu; Y Feng; E R Fearon; K R Cho
Journal:  Oncogene       Date:  2011-04-18       Impact factor: 9.867

Review 3.  Collective cell migration in morphogenesis, regeneration and cancer.

Authors:  Peter Friedl; Darren Gilmour
Journal:  Nat Rev Mol Cell Biol       Date:  2009-07       Impact factor: 94.444

4.  The homeobox transcription factor MSX2 partially mediates the effects of bone morphogenetic protein 4 (BMP4) on somatic cell reprogramming.

Authors:  Lilong Lin; Lining Liang; Xiao Yang; Hao Sun; Yuan Li; Duanqing Pei; Hui Zheng
Journal:  J Biol Chem       Date:  2018-08-10       Impact factor: 5.157

5.  MSX2 mediates entry of human pluripotent stem cells into mesendoderm by simultaneously suppressing SOX2 and activating NODAL signaling.

Authors:  Qingqing Wu; Leisheng Zhang; Pei Su; Xiaohua Lei; Xin Liu; Hongtao Wang; Lisha Lu; Yang Bai; Tao Xiong; Dong Li; Zhengmao Zhu; Enkui Duan; Erlie Jiang; Sizhou Feng; Mingzhe Han; Yuanfu Xu; Fei Wang; Jiaxi Zhou
Journal:  Cell Res       Date:  2015-10-02       Impact factor: 25.617

Review 6.  Role of Cripto-1 during epithelial-to-mesenchymal transition in development and cancer.

Authors:  Maria C Rangel; Hideaki Karasawa; Nadia P Castro; Tadahiro Nagaoka; David S Salomon; Caterina Bianco
Journal:  Am J Pathol       Date:  2012-04-26       Impact factor: 4.307

7.  MSX2 inhibits the growth and migration of osteosarcoma cells by repressing SOX2.

Authors:  Yue Wu; Yi Jin; Norio Yamamoto; Akihiko Takeuchi; Shinji Miwa; Hiroyuki Tsuchiya; Zhijun Yang
Journal:  Am J Transl Res       Date:  2021-06-15       Impact factor: 4.060

Review 8.  Epithelial-mesenchymal transition in cancer: parallels between normal development and tumor progression.

Authors:  Douglas S Micalizzi; Susan M Farabaugh; Heide L Ford
Journal:  J Mammary Gland Biol Neoplasia       Date:  2010-05-19       Impact factor: 2.673

9.  Homeobox transcription factor muscle segment homeobox 2 (Msx2) correlates with good prognosis in breast cancer patients and induces apoptosis in vitro.

Authors:  Fiona Lanigan; Gabriela Gremel; Rowena Hughes; Donal J Brennan; Finian Martin; Karin Jirström; William M Gallagher
Journal:  Breast Cancer Res       Date:  2010-08-03       Impact factor: 6.466

10.  Increased levels of active c-Src distinguish invasive from in situ lobular lesions.

Authors:  Donghui Zou; Han-Seung Yoon; Ahmad Anjomshoaa; David Perez; Ryuji Fukuzawa; Parry Guilford; Bostjan Humar
Journal:  Breast Cancer Res       Date:  2009-07-07       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.